• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • 2021 State of Survivorship Survey Results Briefing
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2021
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

FDA Building

NCCS Joins Letter Highlighting Impact of Gov’t Shutdown on FDA’s Work on Behalf of Patients

January 22, 2019/in Cancer News, Cancer Policy Blog, NCCS News Issue Statements, NCCS News /by actualize
The National Coalition for Cancer Survivorship (NCCS) joined with 46 other patient and provider organizations to call attention to the impact the government shutdown is having on the work of the Food and Drug Administration (FDA).”On behalf of patients across this country, we are greatly concerned that the agency is currently not fully funded, and thousands of vital FDA employees are not working or able to operate at full capacity. While we applaud Commissioner Gottlieb, FDA leadership, and ‘essential staff’ for truly heroic work to keep many aspects of its mission functioning, we fear that this continued shutdown not only puts the current health and safety of Americans at risk, but has begun to put future scientific discovery and innovation in jeopardy.”Read the letter below or download here. (right-click, save as)


January 22, 2019

President Donald J. Trump
The White House
1600 Pennsylvania Ave, NW
Washington, DC 20500

The Honorable Nancy Pelosi
Speaker
U.S. House of Representatives
Washington, DC 20510

The Honorable Kevin McCarthy
Minority Leader
U.S. House of Representatives
Washington, DC 20515

The Honorable Mitch McConnell
Majority Leader
U.S. Senate
Washington, DC 20510

The Honorable Chuck Schumer
Minority Leader
U.S. Senate
Washington, DC 20510

Dear Mr. President, Speaker Pelosi, Leader McConnell, Leader Schumer, and Leader McCarthy,

The undersigned organizations, representing millions of American patients, caregivers, healthcare providers, and researchers write to raise alarm at the continued government shutdown – particularly its impact on the U.S. Food and Drug Administration (FDA). The work of the FDA to protect the health and wellbeing of our nation cannot be overstated. The agency regulates one quarter of the U.S. economy, ensures a safe food supply, protects patients from contaminated and unsafe medical products and, importantly, is the catalyst for expediting lifesaving therapies to patients.

On behalf of patients across this country, we are greatly concerned that the agency is currently not fully funded, and thousands of vital FDA employees are not working or able to operate at full capacity. While we applaud Commissioner Gottlieb, FDA leadership, and “essential staff” for truly heroic work to keep many aspects of its mission functioning, we fear that this continued shutdown not only puts the current health and safety of Americans at risk, but has begun to put future scientific discovery and innovation in jeopardy.

The ongoing government shutdown forces the FDA to make difficult choices regarding to which essential functions its greatly reduced resources are directed. These are decisions that never should have to be made—the health and safety of Americans today should never be weighed against the prospect of new life-saving therapies for patients. Tragically, that is what is happening.

We ask that the President and Congress act immediately to bring the FDA back to its full capacity. Americans’ health and patients’ futures are at stake.

Sincerely,

Acromegaly Community
Addario Lung Cancer Medical Institute
AIM at Melanoma
AliveAndKickn
Alliance for Aging Research
American Academy of Pediatrics
American Society of Clinical Oncology (ASCO)
American Society of Gene & Cell Therapy
Annie Appleseed Project
Association of American Cancer Institutes (AACI)
Bonnie J. Addario Lung Cancer Foundation
Bridge the Gap – SYNGAP Education and Research Foundation
CancerCare
Children’s Cause for Cancer Advocacy
Cutaneous Lymphoma Foundation
Facing Our Risk of Cancer Empowerment (FORCE)
Fight Colorectal Cancer
Friends of Cancer Research
Institute of Clinical Bioethics, Saint Joseph’s University
Kidney Cancer Action Network (KCAN)
Leukemia & Lymphoma Society
Living Beyond Breast Cancer
Lung Cancer Alliance
LUNGevity Foundation
Lupus and Allied Diseases Association, Inc
Lymphoma Research Foundation
Melanoma Research Foundation (MRF)
Men’s Health Network
National Alliance on Mental Illness
National Coalition for Cancer Survivorship (NCCS)
National Consumers League
National Multiple Sclerosis Society
National Organization for Rare Diseases (NORD)
National Osteoporosis Foundation
National Patient Advocate Foundation
NTM Info & Research, Inc.
Ovarian Cancer Research Alliance
Pancreatic Cancer Action Network
Patients for Affordable Drugs
Personalized Medicine Coalition
Prevent Cancer Foundation
Research Advocacy Network
Research!America
St. Baldrick’s Foundation
Stand Up To Cancer
Swifty Foundation


Related Posts

https://canceradvocacy.org/blog/nccs-expresses-reservations-effectiveness-cms-drug-pricing-proposal/

https://canceradvocacy.org/blog/nccs-joins-clc-letter-hhs-drug-pricing-blueprint-american-patients-first/

Tags: cancer care, FDA, issue statement
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/FDA-Building.jpg 515 1030 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2019-01-22 17:28:362020-11-23 10:49:40NCCS Joins Letter Highlighting Impact of Gov’t Shutdown on FDA’s Work on Behalf of Patients

Latest News

Beyond the Checkbox: Cancer Survivorship Care Delivery in the Community - Dr. Crystal Labbato

Webinar – Beyond the Checkbox: Delivering Meaningful Cancer Survivorship Care in a Community Setting

May 20, 2022
Last week, NCCS hosted a conversation with cancer control expert and epidemiologist Otis Brawley, MD. NCCS CEO Shelley Fuld Nasso moderated the discussion. “We knew exactly who we wanted to be our first guest speaker in this series. Dr. Otis Brawley is a Bloomberg Distinguished Professor at Johns Hopkins University, an oncologist and an epidemiologist. [...]
Read more
https://canceradvocacy.org/wp-content/uploads/Beyond-the-Checkbox-Crystal-Labbato.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-20 13:39:272022-05-20 13:39:27Webinar – Beyond the Checkbox: Delivering Meaningful Cancer Survivorship Care in a Community Setting
Michelle Mollica PhD Webinar Survivorship Needs for People with Metastatic and Advanced Cancers

Webinar: Survivorship Needs for People Living with Advanced and Metastatic Cancers

May 6, 2022
Last week, NCCS hosted a conversation with cancer control expert and epidemiologist Otis Brawley, MD. NCCS CEO Shelley Fuld Nasso moderated the discussion. “We knew exactly who we wanted to be our first guest speaker in this series. Dr. Otis Brawley is a Bloomberg Distinguished Professor at Johns Hopkins University, an oncologist and an epidemiologist. [...]
Read more
https://canceradvocacy.org/wp-content/uploads/Webinar-Michelle-Mollica-Metastatic-Survivorship-Needs.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-06 11:32:162022-05-06 12:35:15Webinar: Survivorship Needs for People Living with Advanced and Metastatic Cancers

Erin McGee Ferrell: The Art of Cancer Advocacy

May 5, 2022
Advocate Spotlight May 2022 - Erin McGee Ferrell Erin McGee Ferrell’s cancer…
Read more
https://canceradvocacy.org/wp-content/uploads/Erin-McGee-Ferrell-Advocate-Spotlight-1200px.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-05 12:00:402022-05-05 12:03:28Erin McGee Ferrell: The Art of Cancer Advocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • 2021 State of Survivorship Survey Results Briefing
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2021
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Health Care Roundup: Opposing Medicare Part D Changes; Medicare-for-All... NCCS Starburst 250px NCCS Starburst 250px Health Care Roundup: Gov’t Shutdown Affects FDA; Health Care Hearings;...
Scroll to top
Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute